Tongfang Kontafarma Holdings Overview
- Year Founded
-
1993
- Status
-
Public
- Employees
-
616
- Stock Symbol
-
01312
- Investments
-
3
Tongfang Kontafarma Holdings General Information
Description
Kontafarma China Holdings Ltd and its subsidiaries are principally engaged in the pharmaceutical and fitness business. The Group manufactures and sells prescription drugs, including chemical drugs, traditional Chinese medicine prescriptions, active pharmaceutical ingredients, and API intermediates in China, and operates fitness centres, provides fitness and health consultation services, and operates a franchise business for royalty fee income. Its segments are the pharmaceutical business, which generates maximum revenue, and the fitness business. The Group operates in Mainland China, Singapore, Taiwan, and other regions, with maximum revenue from Mainland China.
Contact Information
Website
www.kontafarma.com.hkCorporate Office
- 9th Floor, Allied Kajima Building
- 138 Gloucester Road, Wanchai
- Hong Kong
- Hong Kong
Corporate Office
- 9th Floor, Allied Kajima Building
- 138 Gloucester Road, Wanchai
- Hong Kong
- Hong Kong
Tongfang Kontafarma Holdings Stock Performance
As of 12-Nov-2026, Tongfang Kontafarma Holdings’s current market cap is $21.4M with 5.59B shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $21.4M | 5.59B | 1.16M |
Tongfang Kontafarma Holdings Financials Summary
As of 30-Jun-2026, Tongfang Kontafarma Holdings has a trailing 12-month revenue of $108M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 27,687 | 32,838 | 44,822 | 54,969 |
| Revenue | 108,207 | 117,326 | 115,019 | 103,345 |
| EBITDA | (12,801) | (45,519) | 1,118 | 9,579 |
| Net Income | (27,240) | (54,878) | (9,680) | (3,684) |
| Total Assets | 127,201 | 136,887 | 204,474 | 221,048 |
| Total Debt | 24,202 | 26,175 | 38,280 | 42,720 |
Tongfang Kontafarma Holdings Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Tongfang Kontafarma Holdings Signals
Tongfang Kontafarma Holdings Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Tongfang Kontafarma Holdings Investments (3)
Tongfang Kontafarma Holdings’s most recent deal was a Secondary Transaction - Private with Tongfang Pharmaceutical Group for . The deal was made on 03-May-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Tongfang Pharmaceutical Group | 03-May-2018 | Secondary Transaction - Private | Pharmaceuticals | ||
| Binex (Busan) | 30-Jun-2017 | PIPE | Other Pharmaceuticals and Biotechnology | ||
| Tongfang Pharmaceutical Group | 28-Jan-2016 | Secondary Transaction - Private | Pharmaceuticals |
Tongfang Kontafarma Holdings ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Construction Materials
Industry
Rank
Percentile
Construction Materials
Subindustry
Rank
Percentile
Tongfang Kontafarma Holdings Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Tongfang Pharmaceutical Group | Beijing, China | 2007 |
Tongfang Kontafarma Holdings FAQs
-
When was Tongfang Kontafarma Holdings founded?
Tongfang Kontafarma Holdings was founded in 1993.
-
Where is Tongfang Kontafarma Holdings headquartered?
Tongfang Kontafarma Holdings is headquartered in Hong Kong, Hong Kong.
-
What is the size of Tongfang Kontafarma Holdings?
Tongfang Kontafarma Holdings has 616 total employees.
-
What industry is Tongfang Kontafarma Holdings in?
Tongfang Kontafarma Holdings’s primary industry is Holding Companies.
-
Is Tongfang Kontafarma Holdings a private or public company?
Tongfang Kontafarma Holdings is a Public company.
-
What is Tongfang Kontafarma Holdings’s stock symbol?
The ticker symbol for Tongfang Kontafarma Holdings is 01312.
-
What is the current market cap of Tongfang Kontafarma Holdings?
The current market capitalization of Tongfang Kontafarma Holdings is $21.4M.
-
What is Tongfang Kontafarma Holdings’s current revenue?
The trailing twelve month revenue for Tongfang Kontafarma Holdings is $108M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process